Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- SkyePharma plc

23 Dec 2005 11:51

HBOS PLC23 December 2005 F tFORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing (Note 1) HBOS plc and its subsidiaries Company dealt in SkyePharma plc Class of relevant security to which the Ord 10pdealings being disclosed relate (Note 2) Date of dealing 22 December 2005 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%)(1) Relevant securities 68,490,202 (9.086%)(2) Derivatives (other than options)(3) Options and agreements to purchase/sellTotal 68,490,202 (9.086%) Nil (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%)(1) Relevant securities(2) Derivatives (other than options)(3) Options and agreements to purchase/sellTotal Nil Nil (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) Purchase 8,363 £0.510 (b) Derivatives transactions (other than options) Product name, e.g. Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5)CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Option moneypaid/name,e.g. call selling, securities to price American, date received per unitoption purchasing, which the European etc. (Note 5) varying etc. option relates (Note 7) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. N/A .............................................................................. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 23 December 2005 Contact name Kenny Melville Telephone number 0131 243 8671 If a connected EFM, name of offeree/offeror with whichconnected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd May 20163:30 pmRNSForm 8.3 - [VEC/SKP]
23rd May 20163:30 pmRNSForm 8.3 - [SKP/VEC]
23rd May 20163:20 pmRNSForm 8.3 - Skyepharma PLC
23rd May 20163:08 pmRNSForm 8.3 - Skyepharma Plc
23rd May 201611:59 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
23rd May 201611:05 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
23rd May 20169:59 amBUSForm 8.3 - Skyepharma Plc
23rd May 20169:42 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
20th May 20165:08 pmRNSForm 8.5 (EPT/RI) - Skyepharma PLC Amendment
20th May 20163:30 pmRNSForm 8.3 - [SKP/VEC]
20th May 20163:30 pmRNSForm 8.3 - [VEC/SKP]
20th May 20163:00 pmRNSForm 8.3 - Skyepharma PLC
20th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
20th May 201610:41 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
20th May 20169:25 amRNSForm 8.3 - Vectura Group plc
20th May 20167:00 amRNSRecommended all share merger
19th May 20163:30 pmRNSForm 8.3 - [VEC/SKP]
19th May 20163:30 pmRNSForm 8.3 - [SKP/VEC]
19th May 20163:23 pmRNSForm 8.3 - Skyepharma Plc
19th May 20163:20 pmRNSForm 8.3 - Skyepharma PLC
19th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
19th May 201611:30 amRNSForm 8.3 - Skyepharma Plc
19th May 201611:17 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
19th May 20169:56 amBUSForm 8.3 - Skyepharma Plc
19th May 20169:03 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
18th May 20163:30 pmRNSForm 8.3 - [VEC/SKP]
18th May 20163:30 pmRNSForm 8.3 - [SKP/VEC]
18th May 20163:00 pmRNSForm 8.3 - Skyepharma PLC
18th May 20161:08 pmRNSResult of AGM
18th May 20161:04 pmRNSForm 8.3 - Skepharma Plc
18th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
18th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
18th May 201610:28 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
18th May 20168:55 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
18th May 20167:00 amRNSTrading Statement
17th May 20163:00 pmRNSForm 8.3 - Skyepharma PLC
17th May 20162:11 pmRNSForm 8.3 - Vectura Group Plc
17th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
17th May 201612:00 pmRNSForm 8.5 (EPT/RI) -Vectura Group PLC
17th May 20169:09 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
16th May 20164:43 pmRNSMerger Update
16th May 20163:14 pmRNSForm 8.3 - Skyepharma PLC
16th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
16th May 201610:39 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
16th May 201610:23 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
16th May 20168:55 amBUSForm 8.3 - Skyepharma Plc
13th May 20162:25 pmRNSForm 8.3 - [Skyepharma plc]
13th May 20169:23 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
12th May 20163:29 pmRNSForm 8.3 - Skyepharma PLC
12th May 20162:09 pmRNSForm 8.3 - Skyepharma Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.